BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Kotak maintains overweight on Cipla
Kotak says although recent currency moves a risk to pharma companies the rupee depreciation against dollar to benefit the sector.